Financial results - GREEK BIOLOGICAL PRODUCTS SRL

Financial Summary - Greek Biological Products Srl
Unique identification code: 14105015
Registration number: J2001006991406
Nace: 6820
Sales - Ron
368.190
Net Profit - Ron
-30.786
Employees
1
Open Account
Company Greek Biological Products Srl with Fiscal Code 14105015 recorded a turnover of 2024 of 368.190, with a net profit of -30.786 and having an average number of employees of 1. The company operates in the field of Închirierea şi subînchirierea bunurilor imobiliare proprii sau închiriate having the NACE code 6820.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Greek Biological Products Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 98.876 95.870 112.327 108.116 121.201 127.387 134.476 185.726 338.669 368.190
Total Income - EUR 156.557 143.488 137.911 128.934 135.264 133.083 192.095 339.817 459.161 483.583
Total Expenses - EUR 144.869 155.230 127.670 81.725 107.455 93.599 285.131 489.633 538.654 514.368
Gross Profit/Loss - EUR 11.688 -11.741 10.240 47.209 27.808 39.484 -93.036 -149.815 -79.493 -30.786
Net Profit/Loss - EUR 11.688 -11.741 10.240 46.128 26.596 38.307 -94.405 -151.683 -82.914 -30.786
Employees 1 1 1 0 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 9.3%, from 338.669 euro in the year 2023, to 368.190 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Greek Biological Products Srl

Rating financiar

Financial Rating -
GREEK BIOLOGICAL PRODUCTS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Greek Biological Products Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Greek Biological Products Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Greek Biological Products Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Greek Biological Products Srl - CUI 14105015

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.375.874 1.395.826 1.340.694 1.287.068 1.231.806 1.189.513 3.378.338 3.654.736 3.558.712 3.459.009
Current Assets 168.926 115.823 196.076 275.697 303.324 231.201 726.534 267.704 91.742 16.108
Inventories 0 0 0 0 0 0 33.633 0 0 0
Receivables 37.263 38.849 60.528 87.909 26.821 33.066 550.804 247.514 91.217 15.664
Cash 131.663 76.974 135.548 187.788 276.503 198.135 142.097 20.190 525 444
Shareholders Funds -103.825 -114.508 -102.330 -54.324 -72.997 -33.306 -126.972 -279.049 -361.116 -389.884
Social Capital 174.753 172.971 170.044 166.923 163.690 160.587 157.026 157.513 157.035 156.158
Debts 1.641.699 1.628.983 1.632.494 1.609.786 1.598.415 1.445.547 3.919.452 3.911.360 3.872.295 3.799.465
Income in Advance 9.153 10.171 8.976 9.617 10.861 9.867 313.395 292.656 141.050 67.308
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6820 - 6820"
CAEN Financial Year 6820
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 16.108 euro in 2024 which includes Inventories of 0 euro, Receivables of 15.664 euro and cash availability of 444 euro.
The company's Equity was valued at -389.884 euro, while total Liabilities amounted to 3.799.465 euro. Equity decreased by -30.786 euro, from -361.116 euro in 2023, to -389.884 in 2024. The Debt Ratio was 109.3% in the year 2024.

Risk Reports Prices

Reviews - Greek Biological Products Srl

Comments - Greek Biological Products Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.